<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Increased circulating free fatty acids (FFAs) inhibit both hepatic and peripheral insulin action </plain></SENT>
<SENT sid="1" pm="."><plain>Because the loss of effectiveness of <z:chebi fb="105" ids="17234">glucose</z:chebi> to suppress endogenous <z:chebi fb="105" ids="17234">glucose</z:chebi> production and stimulate <z:chebi fb="105" ids="17234">glucose</z:chebi> uptake contributes importantly to fasting <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, we examined whether the approximate twofold elevations in FFA characteristic of poorly controlled type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> contribute to this defect </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="105" ids="17234">Glucose</z:chebi> levels were raised from 5 to 10 mmol/l while maintaining fixed hormonal conditions by infusing somatostatin with basal insulin, glucagon, and growth hormone </plain></SENT>
<SENT sid="3" pm="."><plain>Each individual was studied at two FFA levels: with (NA+) and without (NA-) infusion of <z:chebi fb="5" ids="15940">nicotinic acid</z:chebi> in nine individuals with poorly controlled type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> (HbA(1c) = 10.1 +/- 0.7%) and with (LIP+) and without (LIP-) infusion of <z:chebi fb="23" ids="18059">lipid</z:chebi> emulsion in nine nondiabetic individuals </plain></SENT>
<SENT sid="4" pm="."><plain>Elevating FFA to approximately 500 micro mol/l blunted the ability of <z:chebi fb="105" ids="17234">glucose</z:chebi> to suppress endogenous <z:chebi fb="105" ids="17234">glucose</z:chebi> production (LIP- = -48% vs. LIP+ = -28%; P &lt; 0.01) and increased <z:chebi fb="105" ids="17234">glucose</z:chebi> uptake (LIP- = 97% vs. LIP+ = 51%; P &lt; 0.01) in nondiabetic individuals </plain></SENT>
<SENT sid="5" pm="."><plain>Raising FFA also blunted the endogenous <z:chebi fb="105" ids="17234">glucose</z:chebi> production response in 10 individuals with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> in good control (HbA(1c) = 6.3 +/- 0.3%) </plain></SENT>
<SENT sid="6" pm="."><plain>Conversely, normalizing FFA nearly restored the endogenous <z:chebi fb="105" ids="17234">glucose</z:chebi> production (NA- = -7% vs. NA+ = -41%; P &lt; 0.001) and <z:chebi fb="105" ids="17234">glucose</z:chebi> uptake (NA- = 26% vs. NA+ = 64%; P &lt; 0.001) responses to <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> in individuals with poorly controlled type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="7" pm="."><plain>Thus, <z:mp ids='MP_0001554'>increased FFA levels</z:mp> contribute substantially to the loss of <z:chebi fb="105" ids="17234">glucose</z:chebi> effectiveness in poorly controlled type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>